137 related articles for article (PubMed ID: 15663182)
1. The age-related increase in N-methyl-2-pyridone-5-carboxamide (NAD catabolite) in human plasma.
Slominska EM; Rutkowski P; Smolenski RT; Szutowicz A; Rutkowski B; Swierczynski J
Mol Cell Biochem; 2004 Dec; 267(1-2):25-30. PubMed ID: 15663182
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of plasma N-methyl-2-pyridone-5-carboxamide in patients with chronic renal failure.
Slominska EM; Smolenski RT; Szolkiewicz M; Leaver N; Rutkowski B; Simmonds HA; Swierczynski J
Mol Cell Biochem; 2002 Feb; 231(1-2):83-8. PubMed ID: 11952169
[TBL] [Abstract][Full Text] [Related]
3. Urinary Excretion of
Deen CPJ; Veen AV; Gomes-Neto AW; Geleijnse JM; Berg KJBD; Heiner-Fokkema MR; Kema IP; Bakker SJL
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32664445
[TBL] [Abstract][Full Text] [Related]
4. N-methyl-2-pyridone-5-carboxamide: a novel uremic toxin?
Rutkowski B; Slominska E; Szolkiewicz M; Smolenski RT; Striley C; Rutkowski P; Swierczynski J
Kidney Int Suppl; 2003 May; (84):S19-21. PubMed ID: 12694300
[TBL] [Abstract][Full Text] [Related]
5. Urinary Excretion of
Deen CPJ; van der Veen A; Gomes-Neto AW; Geleijnse JM; Borgonjen-van den Berg KJ; Heiner-Fokkema MR; Kema IP; Bakker SJL
J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32041099
[No Abstract] [Full Text] [Related]
6. N-methyl-2-pyridone-5-carboxamide (2PY)-Major Metabolite of Nicotinamide: An Update on an Old Uremic Toxin.
Lenglet A; Liabeuf S; Bodeau S; Louvet L; Mary A; Boullier A; Lemaire-Hurtel AS; Jonet A; Sonnet P; Kamel S; Massy ZA
Toxins (Basel); 2016 Nov; 8(11):. PubMed ID: 27854278
[No Abstract] [Full Text] [Related]
7. Plasma and urine pharmacokinetics of niacin and its metabolites from an extended-release niacin formulation.
Menon RM; Adams MH; González MA; Tolbert DS; Leu JH; Cefali EA
Int J Clin Pharmacol Ther; 2007 Aug; 45(8):448-54. PubMed ID: 17725178
[TBL] [Abstract][Full Text] [Related]
8. The effect of N-methyl-2-pyridone-5-carboxamide--A nicotinamide catabolite on poly ADP-rybosylation and oxidative stress injury in endothelial cells.
Slominska EM; Smolenski RT; Osborne F; Swierczynski J; Yacoub MH
Nucleosides Nucleotides Nucleic Acids; 2005; 24(4):259-62. PubMed ID: 16021911
[TBL] [Abstract][Full Text] [Related]
9. N-methyl-2-pyridone-5-carboxamide (N-Me-2PY) has potent anti-fibrotic and anti-inflammatory activity in a fibrotic kidney model: is it an old uremic toxin?
Yoshimura N; Yamada K; Ono T; Notoya M; Yukioka H; Takahashi R; Wakino S; Kanda T; Itoh H
Clin Exp Nephrol; 2023 Nov; 27(11):901-911. PubMed ID: 37490135
[TBL] [Abstract][Full Text] [Related]
10. Enzymes that control the conversion of L-tryptophan-nicotinamide and the urinary excretion ratio (N(1)-methyl-2-pyridone-5-carboxamide + N(1)-methyl-4-pyridone-3-carboxamide)/N(1)-methylnicotinamide in mice.
Shibata K; Morita N; Shibata Y; Fukuwatari T
Biosci Biotechnol Biochem; 2013; 77(10):2105-11. PubMed ID: 24096677
[TBL] [Abstract][Full Text] [Related]
11. Development of a hydrophilic liquid interaction chromatography-high-performance liquid chromatography-tandem mass spectrometry based stable isotope dilution analysis and pharmacokinetic studies on bioactive pyridines in human plasma and urine after coffee consumption.
Lang R; Wahl A; Skurk T; Yagar EF; Schmiech L; Eggers R; Hauner H; Hofmann T
Anal Chem; 2010 Feb; 82(4):1486-97. PubMed ID: 20073472
[TBL] [Abstract][Full Text] [Related]
12. 4-Pyridone-3-carboxamide-1-β-D-ribonucleoside triphosphate (4PyTP), a novel NAD metabolite accumulating in erythrocytes of uremic children: a biomarker for a toxic NAD analogue in other tissues?
Synesiou E; Fairbanks LD; Simmonds HA; Slominska EM; Smolenski RT; Carrey EA
Toxins (Basel); 2011 Jun; 3(6):520-37. PubMed ID: 22069723
[TBL] [Abstract][Full Text] [Related]
13. Correlation between niacin equivalent intake and urinary excretion of its metabolites, N'-methylnicotinamide, N'-methyl-2-pyridone-5-carboxamide, and N'-methyl-4-pyridone-3-carboxamide, in humans consuming a self-selected food.
Shibata K; Matsuo H
Am J Clin Nutr; 1989 Jul; 50(1):114-9. PubMed ID: 2526576
[TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
15. A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk.
Ferrell M; Wang Z; Anderson JT; Li XS; Witkowski M; DiDonato JA; Hilser JR; Hartiala JA; Haghikia A; Cajka T; Fiehn O; Sangwan N; Demuth I; König M; Steinhagen-Thiessen E; Landmesser U; Tang WHW; Allayee H; Hazen SL
Nat Med; 2024 Feb; 30(2):424-434. PubMed ID: 38374343
[TBL] [Abstract][Full Text] [Related]
16. Tryptophan-NAD+ pathway metabolites as putative biomarkers and predictors of peroxisome proliferation.
Delaney J; Hodson MP; Thakkar H; Connor SC; Sweatman BC; Kenny SP; McGill PJ; Holder JC; Hutton KA; Haselden JN; Waterfield CJ
Arch Toxicol; 2005 Apr; 79(4):208-23. PubMed ID: 15838709
[TBL] [Abstract][Full Text] [Related]
17. A novel nucleotide found in human erythrocytes, 4-pyridone-3-carboxamide-1-beta-D-ribonucleoside triphosphate.
Slominska EM; Carrey EA; Foks H; Orlewska C; Wieczerzak E; Sowinski P; Yacoub MH; Marinaki AM; Simmonds HA; Smolenski RT
J Biol Chem; 2006 Oct; 281(43):32057-64. PubMed ID: 16920716
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous measurement of nicotinamide and its catabolites, nicotinamide N-oxide, N(1)-methyl-2-pyridone-5-carboxamide, and N(1)-methyl-4-pyridone-3-carboxamide, in mice urine.
Maeta A; Sano M; Fukuwatari T; Shibata K
Biosci Biotechnol Biochem; 2014; 78(8):1306-9. PubMed ID: 25130730
[TBL] [Abstract][Full Text] [Related]
19. The metabolism of nicotinamide in human liver cirrhosis: a study on N-methylnicotinamide and 2-pyridone-5-carboxamide production.
Pumpo R; Sarnelli G; Spinella A; Budillon G; Cuomo R
Am J Gastroenterol; 2001 Apr; 96(4):1183-7. PubMed ID: 11316167
[TBL] [Abstract][Full Text] [Related]
20. Whole blood NAD and NADP concentrations are not depressed in subjects with clinical pellagra.
Creeke PI; Dibari F; Cheung E; van den Briel T; Kyroussis E; Seal AJ
J Nutr; 2007 Sep; 137(9):2013-7. PubMed ID: 17709435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
